MED Medifast, Inc.
Stable Earnings Power
C 52.9 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
B 70
  • 5yr Avg ROIC 37.8%
  • Operating Margin Trend -4.68 pp/yr

Capital Efficiency

Weight: 15%
A+ 95
  • 5yr Avg ROE 39.3%
  • 5yr Share-Count CAGR -1.8%

Growth Quality

Weight: 15%
F 8
  • 5yr Revenue CAGR -29.1%
  • 5yr EPS CAGR -76.1%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 15%
C+ 61
  • 5yr FCF Margin 6.3%
  • 5yr FCF/NI Conversion 2.79x

Balance Sheet

Weight: 20%
C 54
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 4.39

Stability

Weight: 15%
F 24
  • EPS Volatility (σ/μ) 0.80
  • Piotroski F-Score 3
  • Negative-Revenue Years (5) 3/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

1 of 1 gurus held; 1 trimmed.

Holders
1
Avg Δ position
-66.8%
New buys
0
Full exits
0
As of Q1 2026